This session explores how U.S.-driven science is shaping global cell and gene therapy. Topics include the role of African genetic diversity in advancing precision medicine, decentralized manufacturing to expand access, and economic modeling to support gene therapy delivery in low-resource settings, all aimed at promoting global health equity.
Moderators: Jennifer Adair, PhD, and Terry Flotte, MD, UMass Chan Medical School
Speakers:
- Ambroise Wonkam, MD, PhD, Johns Hopkins University School of Medicine
How African genetics are reframing genetic medicine
- Boro Dropulić, PhD, Caring Cross
Local manufacturing of gene and cell therapies for global access
- Jennifer Adair, PhD, UMass Chan Medical School
Leveraging science to evaluate the economics of gene therapy in low resource settings